MedTrace Logo

Prospective Registration Of Patient Data and Quality of Life in Eye Melanoma Patients

NCT05377957 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-04-15

No results posted yet for this study

Summary

PROQEM is a prospective cohort study among patients diagnosed with uveal melanoma to assess quality of life before and in the first five years after treatment.

Conditions

Interventions

OTHER

Quality of life questionnaires

Collection of patient-reported outcomes concerning general and health-related quality of life and impact of uveal melanoma diagnosis

OTHER

Discrete choice experiment

Assessment of patient preferences for outcomes of proton therapy and enucleation

OTHER

Shared decision-making analysis

Assessment of shared decision-making from the perspective of the patient (by questionnaire), physician (by questionnaire) and a neutral observer (by audiotape), combined with patient-reported satisfaction and regret of the treatment decision (by questionnaire)

OTHER

Impact of side-effects analysis

Assessment of the impact of side-effects by questionnaire

Sponsors & Collaborators

  • Leiden University Medical Center

    lead OTHER

Principal Investigators

  • Nanda Horeweg, Md PhD · Leiden University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-05
Primary Completion
2028-04-01
Completion
2031-04-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05377957 on ClinicalTrials.gov